QUOTED. March 16, 2018. Steven Peikin.
Check out what US Securities and Exchange Commission official Steven Peikin had to say about the implications of the agency’s recent charges and settlement with embattled testing company Theranos.
"There is no exemption from the anti-fraud provisions of the federal securities laws simply because a company is nonpublic, development-stage, or the subject of exuberant media attention." –Steven Peikin, enforcement division co-director, US Securities and Exchange Commission
- Find out more: Theranos' Holmes, Balwani Slammed By SEC For 'Massive Fraud'
Click here for a free trial of Medtech Insight